Response to ‘How to interpret the eGFR in patients with small body surface area’  by Freedberg, Daniel E.
individual’s GFR, and that creatinine clearance (Ccr) using
24-h urine is more useful than estimated GFR (eGFR) in
hospitals. However, we were a little surprised at the author
for expressing the unit of Ccr as ml/min (Ccr-I) rather than
as ml/min per 1.73m2 (Ccr-II).
We applied a modified version of the Bland–Altman plot
on Ccr and eGFR to determine whether their differences
change according to body surface area (BSA).2 For eGFR, we
used the four-variable Modification of Diet in Renal Disease
study equation using the Japanese race factor.3 Among
253 patients with ages above 18 years, 160 patients having
Ccr-II of greater than 60ml/min per 1.73m2 were selected for
the measurement of Ccr-I, Ccr-II, and eGFR (Figure 1a
and b). We also measured Ccr-I, Ccr-II, and eGFR for 93
patients having a Ccr-II of less than 60ml/min per 1.73m2
(Figure 1c and d).
In patients with Ccr-II greater than 60ml/min per 1.73m2,
eGFR became less than Ccr-I or Ccr-II above the BSA
value of approximately 1.73m2, whereas it became greater in
the opposite case. However, such a phenomenon was less seen
in patients with a Ccr-II of less than 60ml/min per 1.73m2
and disappeared statistically between Ccr-II and eGFR.
However, as there were a few cases that showed very big
differences between Ccr-II and eGFR with a small BSA,
caution should be exercised applying eGFR to an individual
patient.
1. Freedberg DE. To eGFR or not to eGFR: here is an intern’s answer. Kidney
Int 2009; 76: 129–130.
2. Bland JM, Altman DG. Statistical methods for assessing agreement
between two methods of clinical measurement. Lancet 1986; 327:
307–310.
3. Imai E, Horio M, Nitta K et al. Estimation of glomerular filtration rate by
the MDRD study equation modified for Japanese patients with chronic
kidney disease. Clin Exp Nephrol 2007; 11: 41–50.
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Park and Kim suggest that estimated GFR (eGFR) may
overestimate creatinine clearance among patients with
relatively poor renal function when it is not corrected
for body surface area (BSA).1 The patient described
had an eGFR of 30.0ml/min per the four-variable
Modification of Diet in Renal Disease equation.2 Her
BSA calculated by the DuBois method was 1.728m2;
therefore, her eGFR remains at 30.0ml/min/m2 even after
correction for BSA.3 However, her measured creatinine
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Figure 1 |Difference plot. Modified Bland–Altman difference plot between (a) creatinine clearance-I (Ccr-I, ml/min), and (b) creatinine
clearance-II (Ccr-II, ml/min per 1.73m2) and estimated GFR (eGFR) against body surface area (BSA) in patients with Ccr460ml/min per 1.73m2
(n¼ 160), and same plots in patients with Ccro60ml/min per 1.73m2 (n¼ 93), (c) and (d), respectively. Correlation coefficients of the differences
between (a) Ccr-I, (b) Ccr-II, and eGFR against BSA were r¼ 0.640 (Po0.001) and r¼ 0.286 (Po0.001), respectively. Correlation coefficients of the
differences between (c) Ccr-I, (d) Ccr-II, and eGFR against BSA were r¼ 0.290 (P¼ 0.005) and r¼ 0.068 (P¼ 0.516), respectively.
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clearance was only 14.6ml/min. I agree with Park and Kim
that eGFR should be applied cautiously to individual
patients.1
1. Park I-Y, Kim T-Y. How to interpret the eGFR in patients with small body
surface area. Kidney Int 2009; 76: 1207–1208.
2. Freedberg DE. To eGFR or not to eGFR: here is an intern’s answer. Kidney
Int 2009; 76: 129–130.
3. DuBois D, DuBois EF. A formula to estimate the approximate surface area
if height and weight be known. Arch Int Med 1916; 17: 863–871.
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To the Editor: We read with interest the recent renal consult
presented by Kiernan et al.1 As the case presented, some cases
of renal artery stenosis (RAS) are resistant to percutaneous
renal angioplasty (PTRA) and necessitate surgical revasculari-
zation. Some of these ‘PTRA-resistant’ cases might be caused
by retroperitoneal fibrosis, including chronic periaortitis, and
steroid therapy would be effective for them.2,3
Retroperitoneal fibrosis, a rare inflammatory disease, presents
symptoms caused by the entrapment of retroperitoneal struc-
tures. It can cause renovascular hypertension by entrapment of
the renal artery, and frequently causes urinary tract obstruc-
tion by entrapment of the ureter.4 Most cases are idiopathic, but
the remainder occur as an inflammatory process secondary to
other factors such as trauma and infections; previous surgery is
a possible primary cause and smoking is a risk factor for retro-
peritoneal fibrosis.3
The image after stent implantation indicated that the
RAS of the presented case was rigid, which would represent
fibrosis surrounding it. As the patient had previous aorto-
renal artery reimplantation and was an active smoker, this
case could be one of retroperitoneal fibrosis. With a patent
renal artery, the atrophic left kidney could have been caused
by a former ureteral obstruction. Sonography and magnetic
resonance imaging could have revealed periarterial thickening
and retroperitoneal soft-tissue mass, which are representative
findings of retroperitoneal fibrosis.2,4
1. Kiernan TJ, Yan BP, Gupta V et al. Unusual case of recurrent renal artery
stenosis: lessons to learn. Kidney Int 2009; 76: 224–228.
2. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006; 367:
241–251.
3. Vaglio A, Buzio C. Chronic periaortitis: a spectrum of diseases. Curr Opin
Rheumatol 2005; 17: 34–40.
4. van Bommel EF. Retroperitoneal fibrosis. Neth J Med 2002; 60: 231–242.
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We thank Tanemoto et al.1 for their letter and agree on the
importance of including other diagnoses of ‘percutaneous
transluminal renal angioplasty-resistant’ renal artery stenosis,
such as retroperitoneal fibrosis (RPF) and chronic aortitis,
that we did not mention in our renal case report.
However, our case does not represent a case of renal
artery stenosis caused by RPF for a number of reasons.
The 39-year-old patient underwent surgical revasculari-
zation for presumed congenital renal artery stenosis at
an outside hospital at a young age. Unfortunately, limited
medical and surgical data were available from that
hospital, but at open repair we found that a synthetic
conduit was used for the initial renal artery revasculariza-
tion as a child.
Magnetic resonance imaging and sonography performed
at our institution did not reveal any evidence of periarterial
thickening or presence of a soft tissue mass in the retro-
peritoneum. The image after stenting described as ‘rigid’ by
Tanemoto et al. probably reflects the non-elastic composi-
tion of the synthetic conduit material and not extrinsic
fibrotic compression.
Surgical exploration and revascularization performed at
our institution did not reveal any particular macroscopic
evidence of RPF but revealed instead a synthetic graft
that was now size mismatched with respect to the mature
right kidney.
1. Tanemoto M, Takeuchi Y, Mishima E et al. Possible cause of recurrent
renal artery stenosis. Kidney Int 2009; 76: 1209.
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